10-Q: Bio Essence Faces Going Concern Amid Zero Cash

Bio Essence Corp. reports improved operational results in continuing segments but faces severe liquidity issues with zero cash and a going concern warning.

Summary

• Bio Essence Corp. reported total revenues from continuing operations of $281,312 for the six months ended June 30, 2025, a significant increase from $41,695 in the prior year, primarily driven by $280,096 in OEM service revenue.
• The company achieved a net income of $59,864 from continuing operations for the three months ended June 30, 2025, a turnaround from a net loss of $215,678 in the same period last year.
• Net loss from continuing operations for the six months ended June 30, 2025, decreased by 56.92% to $145,888, compared to $338,665 in the prior year.
• Cash and equivalents dropped to $0 as of June 30, 2025, from $1,371 at December 31, 2024.
• The working capital deficit worsened to $(2,958,849) as of June 30, 2025, from $(2,522,008) at December 31, 2024, with a current ratio of 0.04:1.
• The company's accumulated deficit increased to $10,595,158 as of June 30, 2025.
• Management explicitly stated that conditions raise substantial doubt about the company's ability to continue as a going concern.
• Disclosure controls and procedures, as well as internal control over financial reporting, were deemed not effective as of June 30, 2025.

Sentiment

Score: 2

Explanation: While there's a positive shift in continuing operations' profitability and cash flow, the company's overall financial position is extremely precarious with zero cash, a worsening working capital deficit, and an explicit going concern warning. The ineffective internal controls add significant risk. The reliance on shareholder loans highlights a lack of external funding access, indicating severe financial instability.

Positives

• Total revenues from continuing operations increased significantly by 574.69% to $281,312 for the six months ended June 30, 2025, primarily due to a shift to OEM service revenue.
• Gross profit from continuing operations rose to $189,232 for the six months ended June 30, 2025, up from $29,187 in the prior year.
• Net loss from continuing operations for the six months ended June 30, 2025, decreased by 56.92% to $145,888, indicating improved operational efficiency.
• The company achieved a net income of $59,864 from continuing operations for the three months ended June 30, 2025, a significant turnaround from a $215,678 net loss in the comparable prior period.
• Net cash provided by operating activities from continuing operations was $141,728 for the six months ended June 30, 2025, compared to a net cash outflow of $19,563 in the prior year, indicating improved operational cash generation.
• Successfully collected outstanding receivables from BEH, which amounted to $202,238 as of December 31, 2024, by May 9, 2025.

Negatives

• Cash and equivalents were $0 as of June 30, 2025, down from $1,371 at December 31, 2024.
• Working capital deficit worsened to $(2,958,849) as of June 30, 2025, from $(2,522,008) at December 31, 2024.
• The current ratio declined to 0.04:1 as of June 30, 2025, from 0.10:1 at December 31, 2024, indicating severe liquidity constraints.
• Accumulated deficit increased to $10,595,158 as of June 30, 2025.
• Total stockholders' equity (deficit) worsened to $(3,114,978) as of June 30, 2025, from $(2,969,090) at December 31, 2024.
• Overall net loss for the six months ended June 30, 2025, was $(145,888), which is worse than the $(81,740) net loss in the prior year, primarily due to the absence of a large gain from discontinued operations in 2024.
• The company incurred a $50,000 loss from security deposit forfeiture due to early termination of a lease.
• Disclosure controls and procedures were concluded to be not effective as of June 30, 2025.
• Internal control over financial reporting (ICFR) was concluded to be not effective as of June 30, 2025.

Risks

• Substantial doubt exists about the company's ability to continue as a going concern due to recurring net losses and a significant accumulated deficit of $10,595,158.
• The company may have difficulty meeting upcoming cash requirements as current liabilities ($3,071,326) significantly exceed current assets ($112,477).
• There is no assurance that the company will be able to obtain additional funding (if needed) on acceptable terms or at all, through a sale of common stock, loans from financial institutions, or other third parties.
• Lack of liquidity could have a material adverse effect on the company's business viability, financial position, results of operations, and cash flows.
• Ineffective disclosure controls and procedures, and internal control over financial reporting, pose a risk of material misstatements or fraud.
• High customer concentration, with two major customers accounting for 67.8% and 24.3% of total sales for the six months ended June 30, 2025.
• High vendor concentration, with two major vendors accounting for 77.7% and 22.3% of total manufacturing service for the six months ended June 30, 2025.
• Uncertainty regarding the negotiation outcome for early termination of the Irvine facility lease, with $1.46 million in associated lease liabilities remaining on the balance sheet.

Future Outlook

Management plans to increase income by strengthening its sales force, providing attractive sales incentive programs, and increasing marketing and promotion activities. The company intends to raise additional funds through private or public offerings or by obtaining loans from banks or other sources. It believes it will need $1.2 million cash to continue current business for the next 12 months. The company is also evaluating the impact of new accounting pronouncements (ASU 2024-03, ASU 2025-01, ASU 2025-02) on its financial statements.

Management Comments

• "The Company plans to increase its income by strengthening its sales force, providing attractive sales incentive programs, and increasing marketing and promotion activities."
• "Management also intends to raise additional funds by way of a private or public offering, or by obtaining loans from banks or others."
• "While the Company believes in the viability of its strategy to generate sufficient revenue and in its ability to raise additional funds on reasonable terms and conditions, there can be no assurances to that effect."
• "The ability of the Company to continue as a going concern is dependent upon the Company’s ability to further implement its business plan and generate sufficient revenue and its ability to raise additional funds by way of a public or private offering."
• "Our current liabilities exceed current assets at June 30, 2025, and we incurred substantial losses. We may have difficulty meeting upcoming cash requirements."
• "As of June 30, 2025, we believe we will need $1.2 million cash to continue our current business for the next 12 months."
• "The Company’s disclosure controls and procedures are not effective to ensure that material information relating to the Company is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC."
• "Our ICFR were not effective at the reasonable assurance level based on those criteria."

Industry Context

Bio Essence Corp. is undergoing a strategic pivot within the health supplement industry, shifting its primary focus from direct product sales to providing OEM (Original Equipment Manufacturer) services after divesting its manufacturing and distribution subsidiaries. This move suggests an adaptation to market demands or a strategy to operate with a more asset-light model. The high customer and vendor concentration in its new OEM service segment indicates either a specialized niche or an early stage in establishing its market presence in this area.

Comparison to Industry Standards

• The company's financial health, marked by zero cash, a significant working capital deficit, and an explicit 'going concern' warning, is substantially below typical industry standards for publicly traded companies in the health supplement or manufacturing sectors.
• Reliance on unsecured, non-interest bearing, and demand-payable loans from major shareholders is not a sustainable or standard financing practice for a healthy public company.
• The reported ineffectiveness of disclosure controls and internal control over financial reporting is a critical governance deficiency, contrasting sharply with the robust control environments expected of publicly listed entities.

Corporate Governance

Related Party Transactions

• Loans from one major shareholder (also the company's senior officer) totaling $428,146 as of June 30, 2025, which are unsecured, non-interest bearing, and payable on demand.
• Loan from another major shareholder for $608,631 as of June 30, 2025, for settling litigation, which is unsecured, non-interest bearing, and payable on demand.
• On May 31, 2023, the Board approved a debt-to-equity conversion where Ms. Yan (CEO and major shareholder) received 5,000,000 common shares for retirement of $2,500,000 debt, resulting in a $50,000 loss on conversion.

Stakeholder Impact

• Shareholders face significant risk of value erosion due to the explicit going concern warning, severe liquidity issues (zero cash, worsening working capital deficit), and ineffective internal controls. Potential for substantial dilution from future capital raises.
• Employees may face job insecurity and uncertainty given the company's precarious financial position and going concern issues.
• Customers could experience disruptions in service or product availability if the company's financial instability impacts its ability to sustain operations or fulfill obligations, especially given high customer concentration.
• Suppliers face increased credit risk and potential delays or non-payment for services or goods provided, particularly with high vendor concentration.
• Creditors, especially those with unsecured loans (like the major shareholders), face a high risk of non-repayment due to the company's severe liquidity constraints and going concern doubt.

Next Steps

• Implement business plan to generate sufficient revenue.
• Strengthen sales force and provide attractive sales incentive programs.
• Increase marketing and promotion activities.
• Raise additional funds via private or public offering or by obtaining loans from banks or others.
• Continue to work on implementing controls and procedures to remedy ineffective disclosure controls and internal control over financial reporting.
• Negotiate early termination of the Irvine facility lease.

Key Dates

Recommendation

Despite a positive shift in continuing operations' profitability for the recent quarter, the company faces severe liquidity challenges, including zero cash and a worsening working capital deficit. The explicit 'going concern' warning, coupled with ineffective internal controls and heavy reliance on unsecured, demand-payable shareholder loans, indicates extreme financial instability and high risk. The overall net loss for the six-month period also worsened compared to the prior year due to the absence of one-time gains. These factors collectively suggest a high probability of further value erosion and potential business failure, making the stock a strong sell.

Keywords

Health supplements, OEM services, Financial reporting, Going concern, Liquidity, Internal controls, SEC filing, Quarterly report, Corporate governance, Risk management, Manufacturing, Distribution